| Literature DB >> 28616344 |
Isaac Pascual1, Amelia Carro2, Pablo Avanzas1, Daniel Hernández-Vaquero1, Rocío Díaz1, Jose Rozado1, Rebeca Lorca1, María Martín1, Jacobo Silva1, César Morís1.
Abstract
Transcatheter aortic valve implantation (TAVI) is a rapidly evolving therapeutic modality currently available for patients with severe aortic stenosis (AS) that are unsuitable for surgery because of technical/anatomical issues or high-estimated surgical risk. Transfemoral approach is the preferred TAVI delivery route when possible. Alternative non-transfemoral access options include transaortic, trans-subclavian and transapical access. Other approaches are also feasible (transcarotid, transcaval, and antegrade aortic) but are restricted to operators and hospitals with experience. The peculiarities of each of the vascular approaches designed for TAVI delivery make it necessary to carefully assess patient's atherosclerotic load and location, arterial size and tortuosity, and presence of mural thrombus. Several clinical trials are currently ongoing and in the near future the indications for these approaches will likely be better defined and extended to a broader spectrum of TAVI candidates.Entities:
Keywords: Transcatheter aortic valve implantation (TAVI); aortic stenosis (AS); approaches; vascular
Year: 2017 PMID: 28616344 PMCID: PMC5462718 DOI: 10.21037/jtd.2017.05.73
Source DB: PubMed Journal: J Thorac Dis ISSN: 2072-1439 Impact factor: 2.895